November 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreNovember 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 01, 2025
The simulators market size is projected to expand from USD 14.72 billion in 2026 to USD 25.53 billion by 2034,...
Read MoreNovember 01, 2025
According to market reasearchers, the global nerve conduits, wraps, protectors, cap, and connectors market is projected to reach US$ 691.98 million by 2034, driven by rising diabetes cases, demand for minimally invasive surgeries, and advancements in nerve repair technologies across North America and Asia-Pacific....
November 01, 2025
According to market estimations, the clavulanic acid series API market, valued at US$ 385 million in 2023, is projected to reach US$ 777.66 million by 2034, driven by rising antibiotic resistance and R&D. North America leads, Asia-Pacific grows fastest, with potassium clavulanate and oral meds dominating....
November 01, 2025
According to research analysis, the global Factor Xa inhibitors market, valued at US$ 22.1 billion in 2023, is projected to reach US$ 41.52 billion by 2034, driven by rising cardiovascular diseases. North America leads, while Asia-Pacific shows fastest growth. Key players include Pfizer, Bayer, and AstraZeneca....
November 01, 2025
According to market projections, the blood plasma fractionation sector is expected to grow from USD 33.52 billion in 2024 to USD 74.74 billion by 2034, reflecting a CAGR of 8.35%. The rising incidences of immunological disorders and the prevalence of rare chronic disorders, increasing awareness about blood donations, and growing research and develo...
November 01, 2025
According to market projections, the global direct oral anticoagulants (DOACs) market is projected to reach US$ 102.36 billion by 2034, growing at a CAGR of 8%. Growth is driven by rising cardiovascular cases, preference for oral Factor Xa inhibitors, and expanding R&D in safer, AI-powered treatments....
November 01, 2025
According to market research studies, the global oral Factor Xa inhibitors market was valued at USD 21.5B in 2023 and is projected to reach USD 41.24B by 2034, growing at a CAGR of 6.1%, driven by rising cardiovascular cases, ease of use, and increasing adoption of drugs like apixaban and rivaroxaban....
November 01, 2025
According to market estimations, the global thrombopoietin receptor agonists industry, valued at US$ 1.85 billion in 2023, is set to reach US$ 3.74 billion by 2034, driven by rising platelet-related disorders like ITP and AML. Key trends include FDA approvals, growing R&D, and increasing use in hospitals. North America leads, while Asia-Pacif...
November 01, 2025
North America dominated the human blood products market, fueled by regular donation drives, widespread facilities and government efforts to improve blood storage and awareness. In the U.S., 6.8 million people donate annually, while 52% of Canadians have needed blood or blood products....
November 01, 2025
According to market forecast, the global oral thrombopoietin receptor agonists market is projected to reach US$ 9.95 billion by 2034, driven by rising cases of thrombocytopenia and advancements in TPO-RAs. North America leads, while Asia-Pacific shows strong growth potential. Key players include Novartis, Sobi, and Shionogi....
November 01, 2025
Eltrombopag Drugs Market: In October 2024, Jiaheng (Zhuhai Hengqin) Pharmaceutical Technology Company Limited gained approval from China's National Medical Products Administration to market Eltrombopag Olamine tablets. Additionally, in November 2023, the U.S. FDA authorized Teva's Alvaiz (eltrombopag) tablets for treating thrombocytopenia in adults...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com